Khadwal, ABiswas, GArora, BKurkure, P ADeshmukh, CShetty, V2006-05-032009-05-302006-05-032009-05-302006-05-03Khadwal A, Biswas G, Arora B, Kurkure PA, Deshmukh C, Shetty V. Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease. Indian Journal of Pediatrics. 2006 May; 73(5): 437-8http://imsear.searo.who.int/handle/123456789/81149Hodgkin's disease survivors are at an increased risk of developing second malignant neoplasms including secondary bone tumors. Common secondary bone tumors are osteogenic sarcoma and fibrosarcoma. Secondary primitive neuroectodermal tumor is extremely rare in this group. We present below, a rare case of secondary PNET in an 8-year-old child with Hodgkin's disease which developed unusually early outside the radiation portal and discuss potential factors responsible for its causation.engAntineoplastic Combined Chemotherapy Protocols --therapeutic useBleomycin --therapeutic useBone NeoplasmsChildDacarbazine --therapeutic useDose FractionationDoxorubicin --therapeutic useFemurHodgkin Disease --therapyHumansMaleMediastinumNeoplasms, Second PrimaryNeuroectodermal Tumors, PrimitiveVinblastine --therapeutic useCase Reports